It's just a typical post GS upgrade dump, back to the bottom of the upchannel. Should trend higher from here, imo. Next "event" that i am looking at is the CC associated w/ the ER, and I think the price will appreciate into ER (~30 days from now i think). Top of channel is about 30, the way I measure it. GL.
This is good news, and follows directly on to the company's 6/10 presentation. DMD is a really significant potential use of 3019. Anticipation of good things coming out of this study is going to help the stock on an ongoing basis, imo, as it should. Second half '15 continues to look good. gl.
All the big vol is on up days. Stock got pushed back a little from the $24 resistance shelf. I think it will be $28 or so by the next ER; people (incl me) will be excited to see/hear about the follow through progress made since the positive GS conference update. Lots to look forward to here in H2 I think.
This seems to be under major accumulation. GS conference was major game changer and passing of ipo lockup expiration period allows sentiment to normalize. 24 was technical resistance, but we're clear of that now, with nothing between here and 30s. Based on GS conference (in part), I think we'll be in 40's by Q1 if not sooner. gl
GS presentation was solid; lots that will be providing good news/sentiments in H2 imo. technically, stock is clear to trade to 23-25. broke downtrend line; lockup expiration has come and gone, down from 40. sellers exhausted. gl.